Integrative structural biology of viruses by Duyvesteyn, HME

Structural insights into Frizzled3 through nanobody modulators by Hillier, J, Zhao, Y, Carrique, L, Malinauskas, T, Ruza, RR, Chang, T, Yi, G, Duyvesteyn, HME, Yu, J, Lu, W, Pardon, E, Steyaert, J, Zhu, Y, Ni, T, Jones, EY

Accelerating drug target inhibitor discovery with a deep generative foundation model by Chenthamarakshan, V, Hoffman, SC, Owen, CD, Lukacik, P, Strain-Damerell, C, Fearon, D, Malla, TR, Tumber, A, Schofield, CJ, Duyvesteyn, HME, Dejnirattisai, W, Carrique, L, Walter, TS, Screaton, GR, Matviiuk, T, Mojsilovic, A, Crain, J, Walsh, MA, Stuart, DI, Das, P

Recombinant expression systems for production of stabilised virus-like particles as next-generation polio vaccines by Sherry, L, Bahar, MW, Porta, C, Fox, H, Grehan, K, Nasta, V, Duyvesteyn, HME, De Colibus, L, Marsian, J, Murdoch, I, Ponndorf, D, Kim, S, Shah, S, Carlyle, S, Swanson, JJ, Matthews, S, Nicol, C, Lomonossoff, GP, Macadam, AJ, Fry, EE, Stuart, DI, Stonehouse, NJ, Rowlands, DJ

The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variants by Liu, C, Zhou, D, Nutalai, R, Duyvesteyn, HME, Tuekprakhon, A, Ginn, HM, Dejnirattisai, W, Supasa, P, Mentzer, AJ, Wang, B, Case, JB, Zhao, Y, Skelly, DT, Chen, RE, Johnson, SA, Ritter, TG, Mason, C, Malik, T, Temperton, N, Paterson, NG, Williams, MA, Hall, DR, Clare, DK, Howe, A, Goulder, PJR, Fry, EE, Diamond, MS, Mongkolsapaya, J, Ren, J, Stuart, DI, Screaton, GR

Potent cross-reactive antibodies following Omicron breakthrough in vaccinees by Nutalai, R, Zhou, D, Tuekprakhon, A, Ginn, HM, Supasa, P, Liu, C, Huo, J, Mentzer, AJ, Duyvesteyn, HME, Dijokaite-Guraliuc, A, Skelly, D, Ritter, TG, Amini, A, Bibi, S, Adele, S, Johnson, SA, Constantinides, B, Webster, H, Temperton, N, Klenerman, P, Barnes, E, Dunachie, SJ, Crook, D, Pollard, AJ, Lambe, T, Goulder, P, Paterson, NG, Williams, MA, Hall, DR, Mongkolsapaya, J, Fry, EE, Dejnirattisai, W, Ren, J, Stuart, DI, Screaton, GR

Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum by Tuekprakhon, A, Nutalai, R, Dijokaite-Guraliuc, A, Zhou, D, Ginn, HM, Selvaraj, M, Liu, C, Mentzer, AJ, Supasa, P, Duyvesteyn, HME, Das, R, Skelly, D, Ritter, TG, Amini, A, Bibi, S, Adele, S, Johnson, SA, Constantinides, B, Webster, H, Temperton, N, Klenerman, P, Barnes, E, Dunachie, SJ, Crook, D, Pollard, AJ, Lambe, T, Goulder, P, Paterson, NG, Williams, MA, Hall, DR, ISARIC4C Consortium, Fry, EE, Huo, J, Mongkolsapaya, J, Ren, J, Stuart, DI, Screaton, GR

A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75 by Huo, J, Dijokaite-Guraliuc, A, Liu, C, Zhou, D, Ginn, HM, Das, R, Supasa, P, Selvaraj, M, Nutalai, R, Tuekprakhon, A, Duyvesteyn, HME, Mentzer, AJ, Skelly, D, Ritter, TG, Amini, A, Bibi, S, Adele, S, Johnson, SA, Paterson, NG, Williams, MA, Hall, DR, Plowright, M, Newman, TAH, Hornsby, H, de Silva, TI, Temperton, N, Klenerman, P, Barnes, E, Dunachie, SJ, Pollard, AJ, Lambe, T, Goulder, P, OPTIC consortium, ISARIC4C consortium, Fry, EE, Mongkolsapaya, J, Ren, J, Stuart, DI, Screaton, GR

Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera by Zhou, D, Dejnirattisai, W, Supasa, P, Liu, C, Mentzer, AJ, Ginn, HM, Zhao, Y, Duyvesteyn, HME, Tuekprakhon, A, Nutalai, R, Wang, B, Paesen, GC, Lopez-Camacho, C, Slon-Campos, J, Hallis, B, Coombes, N, Bewley, K, Charlton, S, Walter, TS, Skelly, D, Lumley, SF, Dold, C, Levin, R, Pollard, AJ, Dong, T, Knight, JC, Crook, D, Lambe, T, Clutterbuck, E, Bibi, S, Flaxman, A, Bittaye, M, Belij-Rammerstorfer, S, Gilbert, S, James, W, Carroll, MW, Klenerman, P, Barnes, E, Dunachie, SJ, Fry, EE, Mongkolsapaya, J, Ren, J, Stuart, DI, Screaton, GR

Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient by Zhou, D, Duyvesteyn, HME, Chen, C-P, Huang, C-G, Chen, T-H, Shih, S-R, Lin, Y-C, Cheng, C-Y, Cheng, S-H, Huang, Y-C, Lin, T-Y, Ma, C, Huo, J, Carrique, L, Malinauskas, T, Ruza, RR, Shah, PNM, Tan, TK, Rijal, P, Donat, RF, Godwin, K, Buttigieg, KR, Tree, JA, Radecke, J, Paterson, NG, Supasa, P, Mongkolsapaya, J, Screaton, GR, Carroll, MW, Gilbert-Jaramillo, J, Knight, ML, James, W, Owens, RJ, Naismith, JH, Townsend, AR, Fry, EE, Zhao, Y, Ren, J, Stuart, DI, Huang, K-YA

Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera by Supasa, P, Zhou, D, Dejnirattisai, W, Liu, C, Mentzer, AJ, Ginn, HM, Zhao, Y, Duyvesteyn, HME, Nutalai, R, Tuekprakhon, A, Wang, B, Paesen, GC, Slon-Campos, J, López-Camacho, C, Hallis, B, Coombes, N, Bewley, KR, Charlton, S, Walter, TS, Barnes, E, Dunachie, SJ, Skelly, D, Lumley, SF, Baker, N, Shaik, I, Humphries, HE, Godwin, K, Gent, N, Sienkiewicz, A, Dold, C, Levin, R, Pollard, AJ, Dong, T, Screaton, GR, Knight, JC, Klenerman, P, Crook, D, Lambe, T, Clutterbuck, E, Bibi, S, Flaxman, A, Bittaye, M, Belij-Rammerstorfer, S, Gilbert, S, Hall, DR, Williams, MA, Paterson, NG, James, W, Carroll, MW, Fry, EE, Mongkolsapaya, J, Stuart, DI

Antibody evasion by the P.1 strain of SARS-CoV-2 by Dejnirattisai, W, Zhou, D, Supasa, P, Liu, C, Mentzer, AJ, Ginn, HM, Zhao, Y, Duyvesteyn, HME, Tuekprakhon, A, Nutalai, R, Wang, B, López-Camacho, C, Slon-Campos, J, Walter, TS, Skelly, D, Costa Clemens, SA, Naveca, FG, Nascimento, V, Nascimento, F, Fernandes da Costa, C, Resende, PC, Pauvolid-Correa, A, Siqueira, MM, Dold, C, Levin, R, Dong, T, Pollard, AJ, Knight, JC, Crook, D, Lambe, T, Clutterbuck, E, Bibi, S, Flaxman, A, Bittaye, M, Belij-Rammerstorfer, S, Gilbert, SC, Carroll, MW, Klenerman, P, Barnes, E, Dunachie, SJ, Paterson, NG, Williams, MA, Hall, DR, Hulswit, RJG, Bowden, TA, Fry, EE, Mongkolsapaya, J, Ren, J, Stuart, DI, Screaton, GR

The antigenic anatomy of SARS-CoV-2 receptor binding domain by Dejnirattisai, W, Zhou, D, Ginn, HM, Duyvesteyn, HME, Spasa, D, Case, JB, Zhao, Y, Walter, TS, Mentzer, AJ, Liu, C, Wang, B, Paesen, GC, Slon-Campus, J, López-Camacho, C, Kafai, NM, Bailey, AL, Chen, RE, Ying, B, Thompson, C, Bolton, J, Fyfe, A, Gupta, S, Tan, TK, Gilbert-Jaramillo, J, James, W, Knight, M, Carroll, MW, Skelly, D, Dold, C, Peng, Y, Levin, R, Dong, T, Pollard, AJ, Knight, JC, Klenerman, P, Temperton, N, Hall, DR, Williams, MA, Paterson, NG, Bertram, FKR, Seibert, CA, Clare, DK, Howe, A, Raedecke, J, Song, Y, Townsend, AR, Huang, K-YA, Fry, EE, Mongkolsapaya, J, Diamond, MS, Ren, J, Stuart, DI, Screaton, GR

SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses by Dejnirattisai, W, Huo, J, Zhou, D, Zahradník, J, Supasa, P, Liu, C, Duyvesteyn, HME, Ginn, HM, Mentzer, AJ, Tuekprakhon, A, Nutalai, R, Wang, B, Dijokaite, A, Khan, S, Avinoam, O, Bahar, M, Skelly, D, Adele, S, Johnson, SA, Amini, A, Ritter, TG, Mason, C, Dold, C, Pan, D, Assadi, S, Bellass, A, Omo-Dare, N, Koeckerling, D, Flaxman, A, Jenkin, D, Aley, PK, Voysey, M, Costa Clemens, SA, Naveca, FG, Nascimento, V, Nascimento, F, Fernandes da Costa, C, Resende, PC, Pauvolid-Correa, A, Siqueira, MM, Baillie, V, Serafin, N, Kwatra, G, Da Silva, K, Madhi, SA, Nunes, MC, Malik, T, Openshaw, PJM, Baillie, JK, Semple, MG, Dunachie, SJ, Lambe, T, Screaton, GR, Pollard, AJ

Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum by Liu, C, Ginn, HM, Dejnirattisai, W, Supasa, P, Wang, B, Tuekprakhon, A, Nutalai, R, Zhou, D, Mentzer, AJ, Zhao, Y, Duyvesteyn, HME, López-Camacho, C, Slon-Campos, J, Walter, TS, Skelly, D, Johnson, SA, Ritter, TG, Mason, C, Costa Clemens, SA, Gomes Naveca, F, Nascimento, V, Nascimento, F, Fernandes da Costa, C, Resende, PC, Pauvolid-Correa, A, Siqueira, MM, Dold, C, Temperton, N, Dong, T, Pollard, AJ, Knight, JC, Crook, D, Lambe, T, Clutterbuck, E, Bibi, S, Flaxman, A, Bittaye, M, Belij-Rammerstorfer, S, Gilbert, SC, Malik, T, Carroll, MW, Klenerman, P, Barnes, E, Dunachie, SJ, Baillie, V, Serafin, N, Ditse, Z, Da Silva, K, Paterson, NG, Williams, MA, Goulder, P, Fry, EE, Ren, J, Stuart, DI, Screaton, GR